Antigen sparing with adjuvanted inactivated polio vaccine based on Sabin strains.


Autoria(s): Westdijk J.; Koedam P.; Barro M.; Steil B.P.; Collin N.; Vedvick T.S.; Bakker W.A.; van der Ley P.; Kersten G.
Data(s)

2013

Resumo

Six different adjuvants, each in combination with inactivated polio vaccine (IPV) produced with attenuated Sabin strains (sIPV), were evaluated for their ability to enhance virus neutralizing antibody titres (VNTs) in the rat potency model. The increase of VNTs was on average 3-, 15-, 24-fold with adjuvants after one immunization (serotypes 1, 2, and 3, respectively). Also after a boost immunization the VNTs of adjuvanted sIPV were on average another 7-20-27 times higher than after two inoculations of sIPV without adjuvant. The results indicate that it is feasible to increase the potency of inactivated polio vaccines by using adjuvants.

Identificador

http://serval.unil.ch/?id=serval:BIB_D835D632579F

isbn:1873-2518 (Electronic)

pmid:23313617

doi:10.1016/j.vaccine.2012.12.076

isiid:000315312600008

Idioma(s)

en

Fonte

Vaccine, vol. 31, no. 9, pp. 1298-1304

Palavras-Chave #Sabin IPV; Oil-in water; PagL; AlOH3; Replicon particles; MPL
Tipo

info:eu-repo/semantics/article

article